# reload+after+2024-01-23 16:45:25.542505
address1§997 Lenox Drive
address2§Suite 100
city§Lawrenceville
state§NJ
zip§08648
country§United States
phone§609 896 9100
fax§609 896 2200
website§https://www.imunon.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Imunon, Inc., a clinical stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development; and ThermoDox for the treatment of hepatocellular carcinoma. It also has two platform technologies, such as TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies; and PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
fullTimeEmployees§31
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Michael H. Tardugno', 'age': 72, 'title': 'Executive Chairman', 'yearBorn': 1951, 'fiscalYear': 2022, 'totalPay': 1578891, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Corinne M. Le Goff M.B.A., Pharm.D.', 'age': 58, 'title': 'CEO, President & Director', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 477730, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jeffrey W. Church CPA', 'age': 66, 'title': 'CFO, Executive VP & Corporate Secretary', 'yearBorn': 1957, 'fiscalYear': 2022, 'totalPay': 548916, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Khursheed  Anwer M.B.A., Ph.D.', 'age': 63, 'title': 'Executive VP & Chief Scientific Officer', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 540872, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Timothy J. Tumminello CPA', 'age': 65, 'title': 'Chief Accounting Officer & Controller', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 108308, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Marianne M. Lambertson', 'title': 'Vice President of Communications & Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Sebastien  Hazard M.D.', 'title': 'Executive VP & Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.86
priceToSalesTrailing12Months§52.245014
currency§USD
dateShortInterest§1702598400
forwardEps§-1.96
exchange§NCM
quoteType§EQUITY
shortName§Imunon, Inc.
longName§Imunon, Inc.
firstTradeDateEpochUtc§920298600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§8c345872-fb05-3c41-be37-d6105d702b42
gmtOffSetMilliseconds§-18000000
targetHighPrice§15.0
targetLowPrice§8.0
targetMeanPrice§12.5
targetMedianPrice§13.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§3.663
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
